Neoadjuvant chemotherapy with dose dense MVAC is associated with improved survival after radical cystectomy compared to other cytotoxic regimens: A tertiary center experience

INTRODUCTION: Neoadjuvant chemotherapy has become standard of care for cisplatin-eligible patients with muscle-invasive bladder cancer qualified to radical cystectomy, providing a modest increase in 5-year overall survival rate. Several regimens are being employed for neoadjuvant treatment, largely...

Descripción completa

Detalles Bibliográficos
Autores principales: Lemiński, Artur, Kaczmarek, Krystian, Byrski, Tomasz, Słojewski, Marcin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565719/
https://www.ncbi.nlm.nih.gov/pubmed/34731219
http://dx.doi.org/10.1371/journal.pone.0259526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565719/
https://www.ncbi.nlm.nih.gov/pubmed/34731219
http://dx.doi.org/10.1371/journal.pone.0259526

Ejemplares similares